As of September 30, 2023, Synbio International Inc. carries a market capitalization of 2.09M, placing it among publicly traded companies globally. Its enterprise value stands at 2.09M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.09M |
| Enterprise Value | 2.09M |
As of September 30, 2023, Synbio International Inc. has 386.14M shares outstanding.
| Shares Outstanding | 386.14M |
These figures are as of September 30, 2023.
| PB Ratio | -33.50 |
| P/TBV Ratio | -33.50 |
As of the close on November 16, 2026, Synbio International Inc. 's stock has declined approximately 92.31% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| 52-Week Price Change | -92.31% |
These figures cover the twelve months ended September 30, 2023.
| Pretax Income | -62,242.00 |
These figures are as of September 30, 2023. Total book value stands at -62,242.00, with working capital of -62,242.00 providing operational flexibility.
| Equity (Book Value) | -62,242.00 |
| Working Capital | -62,242.00 |